Local Thrombolysis in Arterial Occlusive Disease

Slany, J.; Enzenhofer, V.; Karnik, R.
April 1984
Angiology;Apr1984, Vol. 35 Issue 4, p231
Academic Journal
In a series of 38 subjects intra-arterial catheters were used to infuse streptokinase (SK) or urokinase (UK) just proximal to an acute thromboembolic occlusion in 20 limbs or to perfuse SK directly into the obstructing material in 23 extremities with subacute or chronic occlusions by stepwise advancing the catheter until the distal open segment of the artery was reached. Dosage of SK varied between 50,000 U and 400,000 U and was administered during 1 to 4 hours. Patency could be achieved in 16 out of 20 acute occlusions and in 16 out of 23 chronically obstructed vessels within some hours. A systemic hyperlytic state of 12 to 24 hours duration was observed when total dosage of SK exceeded 80,000 U. In 9 patients thrombolysis was immediately followed by angioplasty. Advantage of the described technique is its rapid effectiveness, low cost, high success rate even in chronic femero-popliteal occlusions and its applicability to patients in whom systemic thrombolysis would be considered contraindicated on account of old age or other causes.


Related Articles

  • Thrombolytic Therapy: Agents, Indication, Clinical Performance, and Side Effects. Tilsner, V.; Greul, W. // Vascular Surgery;Mar/Apr1979, Vol. 13 Issue 2, p79 

    Thrombolytic therapy is successful in 70% of fresh occlusions and in over 40% of chronic occlusions. Vascular surgery is often superior to thrombolytic therapy on the arterial side, but inferior on the venous side. Streptokinase acts faster and is considerably cheaper than urokinase, but it...

  • LOCAL UROKINASE IN ARTERIAL THROMBOEMBOLISM. Fiessinger, J. N.; Vayssairat, M.; Juillet, Y.; Janneau, D.; Cormier, J. M.; Housset, E. // Angiology;Oct1980, Vol. 31 Issue 10, p715 

    Selective intra-arterial urokinase (UK) is effective in treating recent arterial thromboembolism. However, usually only partials lysis is achieved and this treatment seems less effective than intravenous streptokinase. At a dose of 37,500 UCTA/hour it does not produce systemic fibrinolysis. This...

  • THROMBOLYTIC TREATMENT OF VENOUS THROMBOEMBOLISM. Gurewich, Victor // Vascular Surgery;Nov/Dec1977, Vol. 11 Issue 6, p341 

    Describes the thrombolytic treatment for deep venous thromboembolism. Objective of thrombolytic therapy; Pharmacologic efficacy of streptokinase and urokinase; Diagnostic procedure for venous thromboembolism.

  • Occluding the left atrial appendage: anatomical considerations. Su, P.; McCarthy, K. P.; Ho, S. Y. // Heart;Sep2008, Vol. 94 Issue 9, p1166 

    Background: Occlusion of the left atrial appendage (LAA) is thought to reduce the risk of thromboembolic events in patients with atrial fibrillation. Objective: To examine the LAA and its relationship to neighbouring structures that may be put at risk when intervening to occlude its os. Methods:...

  • The Effect of Streptokinase Infusion on Chronic Arterial Occlusions and Stenoses. Verstraete, Marc; Vermylen, Joseph; Donati, Maria Benedetta // Annals of Internal Medicine;Mar71, Vol. 74 Issue 3, p377 

    Focuses on the thrombolytic treatment of arterial occlusion using streptokinase. Application of a fixed streptokinase administration scheme; Incidence of thrombolysis as a function of the location of the proximal extremity of the occlusion; Side effects of the streptokinase infusion treatment.

  • Abciximab added to urokinase increased amputation-free survival in peripheral arterial occlusion of the legs. Hiatt, William R. // ACP Journal Club;Jul/Aug2002, Vol. 137 Issue 1, p12 

    Provides information on a study that investigated whether a combination of urokinase and abciximab reduce complications and prolong amputation-free survival better than urokinase alone in patients with peripheral arterial occlusion of the legs. Study design and setting; Main outcome measures;...

  • Urokinase salvages limbs threatened by severe arterial occlusions.  // Geriatrics;Jan94, Vol. 49 Issue 1, p55 

    Presents information on a research from Miami which showed that infusion of the thrombolytic agent urokinase (Abbokinase) significantly decreases the need for limb amputation in patients with severe arteriial occlusions.

  • A Device for Performing Automated Balloon Catheter Inflation Ischemia Studies. Leavesley, Silas J.; Ledkins, Whitley; Rocic, Petra // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Coronary collateral growth (arteriogenesis) is a physiological adaptive response to transient and repetitive occlusion of major coronary arteries in which small arterioles (native collaterals) with minimal to no blood flow remodel into larger conduit arteries capable of supplying adequate...

  • Left Ventricular Thromboembolic Occlusion of the Popliteal Artery Treated Nonoperatively with Local Urokinase Infusion-- A Case Report. Weisman, Irwin D.; Stanchfield, Warren R.; Herzog, Charles A.; Ney, Arthur L.; Blake, David P. // Angiology;Feb1988, Vol. 39 Issue 2, p179 

    Recently streptokinase and urokinase have been shown to be useful in the nonoperative treatment of thromboembolic disease. Urokinase is emerging as a safer and more effective thrombolytic agent when applied either to definitively lyse spontaneous thrombosis where no underlying structural lesion...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics